Evidence map›Paper›PMID 35154000›Full record

ArticleFrontiers in endocrinology2021

Primary Adrenal Lymphoma: Two Case Series From China.

Jinyang Zeng, Fangfang Yan, Yulong Chen, Li Zang, Kang Chen, Zhaohui Lyu, Jingtao Dou, Yiming Mu, Mingzhu Lin, Guoqing Yang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Addison's Disease: Diagnosis and Management Strategies.International journal of general medicine · 2023
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jinyang ZengDepartment of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Fangfang YanDepartment of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Yulong ChenDepartment of Endocrinology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Li ZangDepartment of Endocrinology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Kang ChenDepartment of Endocrinology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Zhaohui LyuDepartment of Endocrinology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Jingtao DouDepartment of Endocrinology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Yiming MuDepartment of Endocrinology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Mingzhu LinDepartment of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Guoqing YangDepartment of Endocrinology, Hainan Branch of People's Liberation Army (PLA) General Hospital, Sanya, China.
Chinese People's Liberation Army · CNFirst Affiliated Hospital of Xiamen University · CNHainan Branch of People's Liberation Army General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Primary adrenal lymphoma (PAL) is a rare form of adrenal mass. We summarize our experience in its clinical presentation, biochemical indexes, radiological features, pathological information, therapy regimens, and outcomes. Methods: This was an institutional review board-approved retrospective review of medical records and surgical pathology specimens of patients with a diagnosis of PAL at the Chinese People's Liberation Army General Hospital and the First Affiliate Hospital of Xiamen University between July 2007 and July 2017. Results: Twenty-six patients were identified. The mean age at presentation was 60.84 ± 13.14 years with a male-to-female ratio of 2.25:1 (18:8). The most common presenting symptoms were loss of appetite (65%, 17/26), weight loss (62%, 16/26), abdominal pain (58%, 15/26), and fatigue (58%, 15/26). The levels of lactate dehydrogenase (75%, 15/20), β Conclusion: PAL is a rare disease. The clinical characteristics of PAL include loss of appetite and weight loss. Endocrine evaluation should be performed to determine whether patients have adrenal insufficiency, especially patients with bilateral lesions. FDG-PET appears to be more accurate than other imaging modalities in revealing extra-adrenal sites. Better therapy is required to improve the poor prognosis of PAL.

Indexed as

Abdominal PainAdrenalectomyAdrenal Gland NeoplasmsAdrenal InsufficiencyAdultAgedAged, 80 and overAnorexiaAntineoplastic Combined Chemotherapy ProtocolsAsparaginasebeta 2-MicroglobulinBlood SedimentationChinaC-Reactive ProteinCyclophosphamideDexamethasoneAsparaginasebeta 2-MicroglobulinC-Reactive ProteinCyclophosphamideDexamethasoneDimethoateDoxorubicinEtoposideFerritinsL-Lactate DehydrogenaseMethotrexatePrednisoneR-CHOP protocolRituximabVincristineadrenal insufficiencyclinical featureshistologyimagingprimary adrenal lymphoma

Identifiers

PMID35154000
PMCPMC8832485
OpenAlexW4212974704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.